Skip to main content
Figure 5 | BMC Cancer

Figure 5

From: Impact of preoperative anemia on relapse and survival in breast cancer patients

Figure 5

LRFS, LNMFS, DMFS, RFS, and OS for patients in stage III with and without anemia. A. LRFS for patients with Hb ≥12 g/dL versus Hb <12 g/dL in stage III. B. LNMFS for patients with Hb ≥12 g/dL versus Hb <12 g/dL in stage III. C. DMFS for patients with Hb ≥12 g/dL versus Hb <12 g/dL in stage III. D. RFS for patients with Hb ≥12 g/dL versus Hb <12 g/dL in stage III. E. OS for patients with Hb ≥12 g/dL versus Hb <12 g/dL in stage III.

Back to article page
\